BioMap, a life sciences AI large model company supported by Baidu and founded under the leadership of Li Yanhong, has confidentially submitted its listing application to the Hong Kong Stock Exchange, with plans to raise several hundred million US dollars. Previously, Liu Wei, CEO of BioMap, stated that the company plans to seek a public listing in Hong Kong within the next year and a half. Currently, Baidu has not yet responded to this matter.
